Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

BTB09089

🥰Excellent
Catalog No. T67892Cas No. 245728-44-3
Alias GPR65 agonist (BTB09089)

BTB09089 (GPR65 agonist ) is a T cell death-associated gene 8 (TDAG8/GPR65)-specific agonist.BTB09089 induces TDAG8 expression and regulates cytokine production in T cells and macrophages.

BTB09089

BTB09089

🥰Excellent
Purity: 100%
Catalog No. T67892Alias GPR65 agonist (BTB09089)Cas No. 245728-44-3
BTB09089 (GPR65 agonist ) is a T cell death-associated gene 8 (TDAG8/GPR65)-specific agonist.BTB09089 induces TDAG8 expression and regulates cytokine production in T cells and macrophages.
Pack SizePriceAvailabilityQuantity
1 mg$65In Stock
5 mg$126In Stock
10 mg$198In Stock
25 mg$361In Stock
50 mg$549In Stock
100 mg$789In Stock
500 mg$1,630In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "BTB09089"

Select Batch
Purity:100%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
BTB09089 (GPR65 agonist ) is a T cell death-associated gene 8 (TDAG8/GPR65)-specific agonist.BTB09089 induces TDAG8 expression and regulates cytokine production in T cells and macrophages.
In vitro
BTB09089 (0-18 μM; 30 min) significantly increases cAMP accumulation in HEK293 cells expressing hTDAG8 and mTDAG8, but not in control HEK293 cells. It does not enhance cAMP accumulation in HEK293 cells expressing hGPR4 or inositol phosphate accumulation in HEK293 cells expressing hOGR1.[1] BTB09089 (0-18 μM; 30 min) enhances cAMP accumulation dose-dependently at pH 7.0-7.9, but not at pH 6.5.[1] BTB09089 (1-5 μM; 20 h) inhibits IL-2 production in WT mouse splenocytes dose-dependently, without affecting IL-2 production in TDAG8 KO mice or cell viability.[1] BTB09089 (1-5 μM; 18 h) inhibits TNF-α and IL-6 production stimulated by LPS while enhancing IL-10 production in TG-PEC induced by LPS stimulation with sulfated ester.[1]
In vivo
BTB09089 (5-20 μM, 8 μL; i.c.v.; administered 6 hours prior to MCAO) reduces cerebral ischemia-reperfusion injury in rats.[2]
AliasGPR65 agonist (BTB09089)
Chemical Properties
Molecular Weight387.31
FormulaC14H12Cl2N4OS2
Cas No.245728-44-3
SmilesCN1C2=C(SC(SCC3=C(Cl)C=C(Cl)C=C3)=N1)C(=O)N(C)N=C2
Relative Density.1.57 g/cm3 (Predicted)
Storage & Solubility Information
StorageShipping with blue ice.
Solubility Information
DMSO: 3.87 mg/mL (10 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.5819 mL12.9096 mL25.8191 mL129.0956 mL
5 mM0.5164 mL2.5819 mL5.1638 mL25.8191 mL
10 mM0.2582 mL1.2910 mL2.5819 mL12.9096 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy BTB09089 | purchase BTB09089 | BTB09089 cost | order BTB09089 | BTB09089 chemical structure | BTB09089 in vivo | BTB09089 in vitro | BTB09089 formula | BTB09089 molecular weight